217 related articles for article (PubMed ID: 21971477)
1. Complexity of MRI white matter hyperintensity assessments in relation to cognition in aging and dementia from the Sunnybrook Dementia Study.
Gao FQ; Swartz RH; Scheltens P; Leibovitch FS; Kiss A; Honjo K; Black SE
J Alzheimers Dis; 2011; 26 Suppl 3():379-88. PubMed ID: 21971477
[TBL] [Abstract][Full Text] [Related]
2. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
[TBL] [Abstract][Full Text] [Related]
3. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.
Kim JH; Hwang KJ; Kim JH; Lee YH; Rhee HY; Park KC
J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730
[TBL] [Abstract][Full Text] [Related]
4. White matter predictors of cognitive functioning in older adults.
Meier IB; Manly JJ; Provenzano FA; Louie KS; Wasserman BT; Griffith EY; Hector JT; Allocco E; Brickman AM
J Int Neuropsychol Soc; 2012 May; 18(3):414-27. PubMed ID: 22390883
[TBL] [Abstract][Full Text] [Related]
5. Coevolution of white matter hyperintensities and cognition in the elderly.
Maillard P; Carmichael O; Fletcher E; Reed B; Mungas D; DeCarli C
Neurology; 2012 Jul; 79(5):442-8. PubMed ID: 22815562
[TBL] [Abstract][Full Text] [Related]
6. Effect of white matter hyperintensity on medial temporal lobe atrophy in Alzheimer's disease.
Jang JW; Kim S; Na HY; Ahn S; Lee SJ; Kwak KH; Lee MA; Hsiung GY; Choi BS; Youn YC
Eur Neurol; 2013; 69(4):229-35. PubMed ID: 23344183
[TBL] [Abstract][Full Text] [Related]
7. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
[TBL] [Abstract][Full Text] [Related]
8. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.
Yoshita M; Fletcher E; Harvey D; Ortega M; Martinez O; Mungas DM; Reed BR; DeCarli CS
Neurology; 2006 Dec; 67(12):2192-8. PubMed ID: 17190943
[TBL] [Abstract][Full Text] [Related]
9. Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors.
Appel J; Potter E; Bhatia N; Shen Q; Zhao W; Greig MT; Raj A; Barker WW; Potter H; Schofield E; Wu Y; Loewenstein DA; Duara R
AJNR Am J Neuroradiol; 2009 Nov; 30(10):1870-6. PubMed ID: 19643919
[TBL] [Abstract][Full Text] [Related]
10. Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study.
Gouw AA; Van der Flier WM; van Straaten EC; Barkhof F; Ferro JM; Baezner H; Pantoni L; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; Schmidt R; Fazekas F; Scheltens P;
J Neurol; 2006 Sep; 253(9):1189-96. PubMed ID: 16998647
[TBL] [Abstract][Full Text] [Related]
11. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging.
Gootjes L; Teipel SJ; Zebuhr Y; Schwarz R; Leinsinger G; Scheltens P; Möller HJ; Hampel H
Dement Geriatr Cogn Disord; 2004; 18(2):180-8. PubMed ID: 15211074
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative.
Carmichael O; Schwarz C; Drucker D; Fletcher E; Harvey D; Beckett L; Jack CR; Weiner M; DeCarli C;
Arch Neurol; 2010 Nov; 67(11):1370-8. PubMed ID: 21060014
[TBL] [Abstract][Full Text] [Related]
13. Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.
Vipin A; Wong BYX; Kumar D; Low A; Ng KP; Kandiah N
Aging (Albany NY); 2021 Apr; 13(8):10973-10988. PubMed ID: 33861727
[TBL] [Abstract][Full Text] [Related]
14. The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer's Disease.
Horvath A; Quinlan P; Eckerström C; Åberg ND; Wallin A; Svensson J
J Alzheimers Dis; 2024; 99(2):609-622. PubMed ID: 38701139
[TBL] [Abstract][Full Text] [Related]
15. Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment.
Wu A; Sharrett AR; Gottesman RF; Power MC; Mosley TH; Jack CR; Knopman DS; Windham BG; Gross AL; Coresh J
JAMA Netw Open; 2019 May; 2(5):e193359. PubMed ID: 31074810
[TBL] [Abstract][Full Text] [Related]
16. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
Vipin A; Foo HJL; Lim JKW; Chander RJ; Yong TT; Ng ASL; Hameed S; Ting SKS; Zhou J; Kandiah N
J Alzheimers Dis; 2018; 66(2):533-549. PubMed ID: 30320575
[TBL] [Abstract][Full Text] [Related]
17. Topographical differences in white matter hyperintensity burden and cognition in aging, MCI, and AD.
Kamal F; Morrison C; Maranzano J; Zeighami Y; Dadar M
Geroscience; 2023 Feb; 45(1):1-16. PubMed ID: 36229760
[TBL] [Abstract][Full Text] [Related]
18. White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort.
Prasad K; Wiryasaputra L; Ng A; Kandiah N
Dement Geriatr Cogn Disord; 2011; 31(6):431-4. PubMed ID: 21757908
[TBL] [Abstract][Full Text] [Related]
19. Trajectory of white matter hyperintensity burden preceding mild cognitive impairment.
Silbert LC; Dodge HH; Perkins LG; Sherbakov L; Lahna D; Erten-Lyons D; Woltjer R; Shinto L; Kaye JA
Neurology; 2012 Aug; 79(8):741-7. PubMed ID: 22843262
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive visual rating scale of brain magnetic resonance imaging: application in elderly subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
Jang JW; Park SY; Park YH; Baek MJ; Lim JS; Youn YC; Kim S
J Alzheimers Dis; 2015; 44(3):1023-34. PubMed ID: 25380589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
